NCT03445884View on ClinicalTrials.gov

68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Myocardial Angiogenesis

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 20, 2018

Primary Completion Date

July 1, 2020

Study Completion Date

July 1, 2020

Conditions
Acute Myocardial Infarction
Interventions
DRUG

68Ga-NODAGA-E[c(RGDyK)]2

200 MBq 68Ga-NODAGA-E\[c(RGDyK)\]2 administered IV.

Trial Locations (1)

2100

Department of Physiology, Nuclear Medicine and PET, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT03445884 - 68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Myocardial Angiogenesis | Biotech Hunter | Biotech Hunter